On August 13th, the original Google life sciences department, now Alphabet's independent company Life Sciences, announced this week that it will cooperate with well-known continuous blood glucose monitoring system manufacturer DexCom to develop a bandage-sized cloud-connected sensor to help people. Monitor blood sugar levels.
Most of the traditional blood sugar tests use the method of puncturing the fingers to collect blood. This method is not only inconvenient, but also makes people feel uncomfortable in terms of pain. This Life Sciences sensor will be painless, networkable, compact, free to use and low cost, and will provide real-time blood glucose level data.
Collaboration with DexCom is one of two major transactions that Life Sciences has achieved for blood glucose monitoring. In this project, DexCom will be responsible for the development of sensors, and Life Sciences will handle the miniaturization work. In addition, Google's data analysis will also help the product. The two companies can hand over the data collected by the device to Analyze the strength of Google to help patients further improve treatment outcomes and cost control.
It is understood that the product will be launched two or three years later, and it will be iteratively upgraded in the future. It is worth mentioning that the product will be exclusively sold by DexCom. In return, DexCom will pay Life Sciences a value of US$35 million in advance; when the cooperation between the two parties reaches the corresponding node, it will pay another US$65 million in cash. Or equity. Finally, Life Sciences will receive a 5% to 9% royalty fee until the product reaches a specific income level.
This product will become the gospel of diabetic patients, if successful, the majority of patients can not have to worry about measuring blood sugar.
JIANGSU CLS TECHNOLOGY CORP.LTD , https://www.js-cls.com